VIDEX EC - 0087-6674-17 - (didanosine)

Alphabetical Index


Drug Information of VIDEX EC

Product NDC: 0087-6674
Proprietary Name: VIDEX EC
Non Proprietary Name: didanosine
Active Ingredient(s): 400    mg/1 & nbsp;   didanosine
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of VIDEX EC

Product NDC: 0087-6674
Labeler Name: Bristol-Myers Squibb Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021183
Marketing Category: NDA
Start Marketing Date: 20001031

Package Information of VIDEX EC

Package NDC: 0087-6674-17
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0087-6674-17)

NDC Information of VIDEX EC

NDC Code 0087-6674-17
Proprietary Name VIDEX EC
Package Description 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0087-6674-17)
Product NDC 0087-6674
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name didanosine
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20001031
Marketing Category Name NDA
Labeler Name Bristol-Myers Squibb Company
Substance Name DIDANOSINE
Strength Number 400
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of VIDEX EC


General Information